Literature DB >> 22251671

Vaccine applications of flow cytometry.

Stephen C De Rosa1.   

Abstract

Highly effective vaccines have yet to be identified for many widespread infectious diseases including HIV, tuberculosis and malaria. Many vaccine candidates for these diseases have been designed to induce both cellular and humoral immunity, and measurement of the induced cellular immune response and antibody response is critical for monitoring immunogenicity. The flow cytometric intracellular cytokine staining assay is one of the primary assays for enumerating vaccine-induced T cells in vaccine clinical trials. The assay is flexible, allowing for measurement of various cytokines or functions and phenotyping markers, and the assay can be validated. Changes in other cell types such as innate immune cells are monitored by flow cytometric phenotyping assays. Cell sorting of vaccine-induced T cells and B cells is used to allow genomic and transcriptional analysis of these cells. Thus, flow cytometric methods are commonly used in trials testing the next generation of vaccines.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251671      PMCID: PMC3349786          DOI: 10.1016/j.ymeth.2012.01.001

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  32 in total

1.  A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles.

Authors:  Pratip K Chattopadhyay; Joanne Yu; Mario Roederer
Journal:  Nat Med       Date:  2005-09-25       Impact factor: 53.440

2.  Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.

Authors:  Hiroshi Takata; Masafumi Takiguchi
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.

Authors:  Helen Horton; Evan P Thomas; Jason A Stucky; Ian Frank; Zoe Moodie; Yunda Huang; Ya-Lin Chiu; M Juliana McElrath; Stephen C De Rosa
Journal:  J Immunol Methods       Date:  2007-04-03       Impact factor: 2.303

4.  Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.

Authors:  Matthias Wolfl; Jürgen Kuball; William Y Ho; Hieu Nguyen; Thomas J Manley; Marie Bleakley; Philip D Greenberg
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

5.  HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.

Authors:  Stephen C De Rosa; Evan P Thomas; John Bui; Yunda Huang; Allan deCamp; Cecilia Morgan; Spyros A Kalams; Georgia D Tomaras; Rama Akondy; Rafi Ahmed; Chuen-Yen Lau; Barney S Graham; Gary J Nabel; M Juliana McElrath
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

6.  A chemical method for fast and sensitive detection of DNA synthesis in vivo.

Authors:  Adrian Salic; Timothy J Mitchison
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

Review 7.  Cytotoxic T lymphocytes: all roads lead to death.

Authors:  Michele Barry; R Chris Bleackley
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

8.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

9.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

Authors:  Joseph D Miller; Robbert G van der Most; Rama S Akondy; John T Glidewell; Sophia Albott; David Masopust; Kaja Murali-Krishna; Patryce L Mahar; Srilatha Edupuganti; Susan Lalor; Stephanie Germon; Carlos Del Rio; Mark J Mulligan; Silvija I Staprans; John D Altman; Mark B Feinberg; Rafi Ahmed
Journal:  Immunity       Date:  2008-05-08       Impact factor: 31.745

10.  Standardization of cytokine flow cytometry assays.

Authors:  Holden T Maecker; Aline Rinfret; Patricia D'Souza; Janice Darden; Eva Roig; Claire Landry; Peter Hayes; Josephine Birungi; Omu Anzala; Miguel Garcia; Alexandre Harari; Ian Frank; Ruth Baydo; Megan Baker; Jennifer Holbrook; Janet Ottinger; Laurie Lamoreaux; C Lorrie Epling; Elizabeth Sinclair; Maria A Suni; Kara Punt; Sandra Calarota; Sophia El-Bahi; Gailet Alter; Hazel Maila; Ellen Kuta; Josephine Cox; Clive Gray; Marcus Altfeld; Nolwenn Nougarede; Jean Boyer; Lynda Tussey; Timothy Tobery; Barry Bredt; Mario Roederer; Richard Koup; Vernon C Maino; Kent Weinhold; Giuseppe Pantaleo; Jill Gilmour; Helen Horton; Rafick P Sekaly
Journal:  BMC Immunol       Date:  2005-06-24       Impact factor: 3.615

View more
  12 in total

1.  High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.

Authors:  Michał M Bonar; John C Tilton
Journal:  Virology       Date:  2017-02-21       Impact factor: 3.616

Review 2.  The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.

Authors:  Abdulmohammad Pezeshki; Inna G Ovsyannikova; Brett A McKinney; Gregory A Poland; Richard B Kennedy
Journal:  Expert Rev Vaccines       Date:  2019-02-11       Impact factor: 5.217

3.  Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Authors:  Nahiara Esteves Zorgi; Andrés Jimenez Galisteo; Maria Notomi Sato; Nanci do Nascimento; Heitor Franco de Andrade
Journal:  Med Microbiol Immunol       Date:  2016-01-05       Impact factor: 3.402

4.  Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays.

Authors:  Jodi Hagen; Ryan Zimmerman; Christine Goetz; Jody Bonnevier; Jeffrey P Houchins; Kevin Reagan; Alexander E Kalyuzhny
Journal:  Cells       Date:  2015-02-11       Impact factor: 6.600

5.  Minor Antigen Vaccine-Sensitized DLI: In Vitro Responses Do Not Predict In Vivo Effects.

Authors:  Steven Lawrence Rosinski; Brad Stone; Scott S Graves; Deborah H Fuller; James T Fuller; Rainer Storb
Journal:  Transplant Direct       Date:  2016-04-08

Review 6.  Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine.

Authors:  Philippe Moris; Erik Jongert; Robbert G van der Most
Journal:  Hum Vaccin Immunother       Date:  2017-12-01       Impact factor: 3.452

7.  A flow cytometry-based workflow for detection and quantification of anti-plasmodial antibodies in vaccinated and naturally exposed individuals.

Authors:  Anthony Ajua; Thomas Engleitner; Meral Esen; Michael Theisen; Saadou Issifou; Benjamin Mordmüller
Journal:  Malar J       Date:  2012-11-06       Impact factor: 2.979

8.  HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.

Authors:  Claire Ventura; Hélène Bisceglia; Yves Girerd-Chambaz; Nicolas Burdin; Pascal Chaux
Journal:  J Clin Immunol       Date:  2012-07-15       Impact factor: 8.317

Review 9.  Immune monitoring in cancer vaccine clinical trials: critical issues of functional flow cytometry-based assays.

Authors:  Iole Macchia; Francesca Urbani; Enrico Proietti
Journal:  Biomed Res Int       Date:  2013-09-30       Impact factor: 3.411

10.  Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.

Authors:  Susan P Buchbinder; Nicole A Grunenberg; Brittany J Sanchez; Kelly E Seaton; Guido Ferrari; M Anthony Moody; Nicole Frahm; David C Montefiori; Christine M Hay; Paul A Goepfert; Lindsey R Baden; Harriet L Robinson; Xuesong Yu; Peter B Gilbert; M Juliana McElrath; Yunda Huang; Georgia D Tomaras
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.